Genomic profiling of treated high-risk smoldering multiple myeloma

被引：0

作者：

Diamond, Benjamin ^{[1
]}

Kazandjian, Dickran ^{[2
]}

Papadimitriou, Marios ^{[2
]}

Ziccheddu, Bachisio ^{[2
]}

Blaney, Patrick ^{[3
]}

Chojnacka, Monika ^{[1
]}

Durante, Michael ^{[2
]}

Hill, Elizabeth ^{[4
]}

Sklavenitis-Pistofidis, Romanos ^{[5
]}

Davies, Faith ^{[6
]}

Getz, Gad ^{[7
]}

Ghobrial, Irene ^{[8
]}

Morgan, Gareth ^{[6
]}

Maura, Francesco ^{[1
]}

Landgren, Ola ^{[1
]}

机构：

[1] Univ Miami, Myeloma Serv, Sylvester Comprehens Canc Ctr, Coral Gables, FL 33124 USA

[2] Univ Miami, Coral Gables, FL 33124 USA

[3] NYU Langone, Perlmutter Canc Ctr, Myeloma Res Program, New York, NY USA

[4] NCI, Ctr Canc Res, Bethesda, MD 20892 USA

[5] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[6] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA

[7] Harvard Med Sch, Boston, MA 02115 USA

[8] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-342

引用

页码：S227 / S228

页数：2

共 50 条

[11] Treatment for High-Risk Smoldering Myeloma
Dispenzieri, Angela
Kumar, Shaji
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18): : 1764 - 1764
[12] Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma
Kazandjian, Dickran
Diamond, Benjamin
Papadimitriou, Marios
Hill, Elizabeth
Sklavenitis-Pistofidis, Romanos
Ziccheddu, Bachisio
Blaney, Patrick
Chojnacka, Monika
Durante, Michael
Maclachlan, Kylee
Young, Ryan
Usmani, Saad
Davies, Faith
Getz, Gad
Ghobrial, Irene
Korde, Neha
Morgan, Gareth
Maura, Francesco
Landgren, Ola
CLINICAL CANCER RESEARCH, 2024, 30 (19) : 4482 - 4490
[13] Genomic profiling of high-risk smoldering myeloma patients treated with a curative strategy: a biological study of the phase II GEM CESAR clinical trial
Medina, Alejandro
Vazquez, Iria
Cuenca, Isabel
Rosa, Juan Manuel
Jimenez, Cristina
Ariceta, Benat
Fernandez-Guijarro, Manuela
Larrayoz, Maria-Jose
Gutierrez, Norma
Fernandez-Mercado, Marta
Gonzalez-Calle, Veronica
Rodriguez-Otero, Paula
Oriol, Albert
Rosinol, Laura
de la Rubia, Javier
Paiva, Bruno
Palacios, Juan Jose Lahuerta
Blade, Joan
San-Miguel, Jesus
Mateos, Maria-Victoria
Martinez-Lopez, Joaquin
Calasanz, Maria-Jose
Garcia-Sanz, Ramon
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S12 - S13
[14] Daratumumab for high-risk smoldering multiple myeloma-Are we there yet?
Lal, Bhavesh Mohan
Al Hadidi, Samer
EUROPEAN JOURNAL OF CANCER, 2025, 220
[15] High Throughput Genomic Analysis Identifies Low-Risk Smoldering Multiple Myeloma
Aktas-Samur, Anil
Fulciniti, Mariateresa
Derebail, Sanika
Szalat, Raphael
Parmigiani, Giovanni
Corre, Jill
Avet-Loiseau, Herve
Samur, Mehmet K.
Munshi, Nikhil C.
BLOOD, 2020, 136
[16] Should high-risk smouldering multiple myeloma be treated?
Richard, Shambavi
Jagannath, Sundar
Boccadoro, Mario
Mina, Roberto
LANCET HAEMATOLOGY, 2020, 7 (01): : E15 - E16
[17] High-risk smoldering myeloma: Perspective on watchful monitoring
Leng, Siyang
Lentzsch, Suzanne
SEMINARS IN ONCOLOGY, 2016, 43 (06) : 697 - 699
[18] Genomic profiling of smoldering multiple myeloma classifies distinct molecular groups.
Anand, Shankara
Bustoros, Mark
Aguet, Francois
Sklavenitis-Pistofidis, Romanos
Redd, Robert
Zhitomirsky, Benny
Dunford, Andrew J.
Tai, Yu-Tzu
Chavda, Selina J.
Boehner, Cody
Neuse, Carl J.
Casneuf, Tineke
Trippa, Lorenzo
Stewart, Chip
Yong, Kwee
Ghobrial, Irene
Getz, Gad
CANCER RESEARCH, 2021, 81 (13)
[19] The Difficulty in Defining the True High-Risk Smoldering Myeloma
Weinhold, Niels
Rasche, Leo
CLINICAL CANCER RESEARCH, 2024, 30 (19) : 4263 - 4265
[20] High dimensional profiling of the immune microenvironment in smoldering multiple myeloma
Cho, Hearn Jay
Fernandez, Nicolas
Perumal, Deepak
Rahman, Adeeb
Kim-Schulze, Seunghee
Auclair, Daniel
Adams, Homer, III
Parekh, Samir
Gnjatic, Sacha
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E27 - E28

← 1 2 3 4 5 →